ChemicalBook--->CAS DataBase List--->361979-40-0

361979-40-0

361979-40-0 Structure

361979-40-0 Structure
IdentificationBack Directory
[Name]

PCS1055 dihydrochloride
[CAS]

361979-40-0
[Synonyms]

PCS1055 dihydrochloride
PCS1055 dihydrochloride >=98% (HPLC)
[Molecular Formula]

C27H33ClN4
[MDL Number]

MFCD30718586
[MOL File]

361979-40-0.mol
[Molecular Weight]

449.04
Chemical PropertiesBack Directory
[storage temp. ]

2-8°C
[form ]

Solid
[color ]

White to off-white
[Water Solubility ]

H2O: 5mg/mL, clear (warmed)
Hazard InformationBack Directory
[Description]

PCS1055 is a muscarinic M4 receptor antagonist. PCS1055 represents a new M4-preferring antagonist that may be useful in elucidating the roles of M4 receptor signaling.
[Uses]

PCS1055 dihydrochloride is a potent, selective and competitive muscarinic M4 receptor antagonist with an IC50 of 18.1 nM and a Kd of 5.72 nM. PCS1055 dihydrochloride inhibits radioligand [3H]-NMS binding to the M4 receptor with a Ki of 6.5 nM. PCS1055 dihydrochloride exhibits >100-fold selectivity over M1-, M3-, and M5-receptors and 30-fold selectivity at the M2 receptor. PCS1055 dihydrochloride is also a potent AChE inhibitor with IC50 s of 22 nM and 120 nM for electric eel and human AChE, respectively[1][2].
[in vivo]

PCS1055 (30 mg/kg; intraperitoneal injection; male mice) treatment shows the maximal plasma levels at the 30 min time-point with 45100 nM total and 631nM unbound plasma concentrations. The maximal compound exposure observed in the brain is 11.8 nM at 1 h[1].

Animal Model:Male mice[1]
Dosage:30 mg/kg
Administration:Intraperitoneal injection (Pharmacokinetic Analysis)
Result:The maximal plasma levels were observed at the 30 min time-point with 45100 nM total and 631nM unbound plasma concentrations. The maximal compound exposure observed in the brain was 11.8 nM at 1 h.
[IC 50]

AChE; mAChR4
[References]

[1] Croy CH, et al. Characterization of PCS1055, a novel muscarinic M4 receptor antagonist. Eur J Pharmacol. 2016 Jul 5;782:70-6. DOI:10.1016/j.ejphar.2016.04.022
[2] Contreras JM, et al. Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors. J Med Chem. 2001 Aug 16;44(17):2707-18. DOI:10.1021/jm001088u
361979-40-0 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354 , +17819995354
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840 15801484223;
Website: http://www.jm-bio.com/
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Website: www.bestbaiao.com/
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Merck KGaA  
Tel: 21-20338288
Website: www.sigmaaldrich.cn
Tags:361979-40-0 Related Product Information